

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its clinical programs comprise ELVN-001, a small molecule kinase inh...
Q2 2026
Aug 12, 2026
Q1 2026
May 7, 2026
FY 2025
Mar 3, 2026
Q4 2025
Mar 3, 2026
Q3 2025
Nov 12, 2025